Full Press Release Details
VIENNA, Va.--(BUSINESS WIRE)---- $CVM #Multikine--CEL-SCI invited to deliver keynote address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology.
CVM Positive Sentiment
CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology
Key Takeaway: CEL-SCI has been invited to present a keynote address on its product Multikine at the 6th World Congress on Otology, Rhinology, and Laryngology. This invitation underscores the importance of Multikine in the field. The congress provides a platform for sharing advancements in otology, rhinology, and laryngology.
Market Sentiment Analysis
POSITIVE FACTORS
- CEL-SCI has been invited to deliver a keynote address.
- The event highlights the significance of Multikine.
- Participation in a prestigious congress enhances visibility.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceCash runway
~4 mo
High dilution risk
Lead asset
LI
Phase 3 · Squamous Cell Carcinoma of the Oral Cavity
Frequently Asked Questions
What is the significance of the keynote address?
The keynote address highlights the importance of Multikine in its field.
Where will the keynote address take place?
It will be delivered at the 6th World Congress on Otology, Rhinology, and Laryngology.
Who is delivering the keynote address?
CEL-SCI has been invited to deliver the keynote address.